KALI SULPHURICUM

Manufacturer
SEVENE USA
Effective date
2025-02-11
Label type
HUMAN OTC DRUG LABEL
Version
4
Source
full-release
Hydrated at
2026-06-01 02:32:07

Label at a glance#

ProductKALI SULPHURICUM 6X
Active ingredientPOTASSIUM SULFATE
Label structure11 sections

Indications and uses

Itching rash, scaly and chapped skin, and infected skin with yellow discharge**. **C, K, CK & X are homeopathic dilutions.

Dosage and administration

(adults/children) Dissolve 5 pellets under the tongue three times a day until symptoms are relieved or as directed by a doctor.

Label contents#

Full prescribing information#

ACTIVE INGREDIENT:

OTC - ACTIVE INGREDIENT SECTION

KALI SULPHURICUM 6X**

**C, K, CK & X are homeopathic dilutions.

TRADITIONALLY USED FOR TEMPORARY RELIEF FROM:

OTC - PURPOSE SECTION

Itching rash, scaly and chapped skin, and infected skin with yellow discharge*

*Claims based on traditional homeopathic practice, not accepted medical evidence. Not FDA evaluated.

DIRECTIONS:

DOSAGE & ADMINISTRATION SECTION

  • (adults/children) Dissolve 5 pellets under the tongue three times a day until symptoms are relieved or as directed by a doctor.

USES:

INDICATIONS & USAGE SECTION

Itching rash, scaly and chapped skin, and infected skin with yellow discharge**.

**C, K, CK & X are homeopathic dilutions.

WARNINGS

WARNINGS SECTION

  • Stop use and ask a doctor if symptoms persist for more than 3 days or worsen.

OTC - PREGNANCY OR BREAST FEEDING SECTION

  • If pregnant or breast-feeding, ask a health professional before use.

OTC - KEEP OUT OF REACH OF CHILDREN SECTION

  • Keep out of reach of children.
  • In case of overdose, get medical help.

OTHER INFORMATION:

OTHER SAFETY INFORMATION

  • Store at room temperature.
  • Do not use if tamper-evidence seal is broken.
  • Organic verified by Alpes Control 2021/A03M216K/1.

**C, K, CK & X are homeopathic dilutions

INACTIVE INGREDIENT:

INACTIVE INGREDIENT SECTION

ORGANIC SUCROSE

QUESTIONS OR COMMENTS?

OTC - QUESTIONS SECTION

Email us at: info@ollois.com

PACKAGE LABEL.PRINCIPAL DISPLAY PANEL

01b LBL_Kali Sulphuricum_6X_80ct01b LBL_Kali Sulphuricum_6X_80ct

DailyMed Product Concepts#

Product concept, Relation, Version table
Product conceptRelationVersionEffective
95250459-30e4-45c1-b08a-993044f49109Product name220250805
26acd337-b838-40ac-bcbc-05c3b81c8712Product name120170323

FDA-Initiated Inactive NDC Indexing#

DailyMed Package Descriptions#

Package NDC, Product, Description table
Package NDCProductDescriptionFormQuantityStrengthSPL version
76472-4094-1KALI SULPHURICUM6X80 in 1 CYLINDERPELLET804

DailyMed Dashboard NDC Coverage#

NDC, Dashboard title, SPL version table
NDCDashboard titleSPL versionValidationDashboard ZIP
76472-4094KALI SULPHURICUM 6X (KALI SULPHURICUM) PELLET [SEVENE USA]4Current NDC, 1 package rows20250213_ff0efbc2-d7ab-9783-e053-6394a90a384f.zip

Products#

Every source-derived product name is available through these pages.

DailyMed product names page 1 of 1 · 5 matching rows.

NDC Codes#

Product NDC, Package NDC table
Product NDCPackage NDC
76472-409476472-4094-1

Ingredients#

Every source-derived ingredient row is available through these pages.

DailyMed ingredient rows page 1 of 1 · 2 matching rows.

Name, UNII, Kind table
NameUNIIKind
SUCROSEC151H8M554IACT
POTASSIUM SULFATE1K573LC5TVACTIB

Source Document#

Source XML

openFDA label cross-check#

OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.

Matched openFDA labels page 1 of 1 · 1 matching rows.

Brand, Generic, Manufacturer table
BrandGenericManufacturerSPL set IDEffective dateAvailable safety fieldsJoin
KALI SULPHURICUM 6XKALI SULPHURICUMSEVENE USAff0efbc2-d7ab-9783-e053-6394a90a384f2025-02-11WarningsExact identifier
ndc (package): 76472-4094-1
ndc (product): 76472-4094
ndc11 (package): 76472409401
spl id: 2ddc53bf-0bf5-fb07-e063-6394a90aa1cd
spl set id: ff0efbc2-d7ab-9783-e053-6394a90a384f

Reported adverse events (FAERS/openFDA)#

Adverse event summaries are temporarily unavailable. Other product information remains available.